Analysts Set United Therapeutics Co. (NASDAQ:UTHR) PT at $392.00
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have received a consensus rating of “Moderate Buy” from the twelve brokerages that are covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year price […]
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have received a consensus rating of “Moderate Buy” from the twelve brokerages that are covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year price […]
